Loading...
•
Oct 03, 2021
Revvity Q3 2021 Earnings Report
PerkinElmer's Q3 2021 earnings were announced, featuring a 21% increase in reported revenue and a 12% increase in organic revenue. The company's GAAP EPS was $1.11, and adjusted EPS reached $2.31. The company initiated Q4 guidance and raised full year revenue and earnings guidance.
Key Takeaways
PerkinElmer reported a strong third quarter with a 21% increase in revenue to $1.17 billion and adjusted EPS of $2.31. The company also provided an optimistic outlook by raising full-year revenue and earnings guidance.
Revenue reached $1.17 billion, showcasing a 21% reported growth and 12% organic growth.
GAAP EPS from continuing operations was reported at $1.11.
Adjusted EPS was $2.31, exceeding the prior year's performance.
The company initiated Q4 guidance and raised full year revenue and earnings guidance.
Revvity
Revvity
Revvity Revenue by Segment
Revenue by Segment
Diagnostics Revenue
CapyFin.com Forward Guidance
For the fourth quarter of 2021, the Company forecasts adjusted revenue of approximately $1.2 billion and adjusted earnings per share of $2.05. For the full year 2021, the Company now forecasts adjusted revenue of $4.9 billion and adjusted earnings per share of $10.81.